VIR - Vir Biotechnology files for a mixed shelf offering
2023-11-03 16:46:43 ET
More on Vir Biotechnology
- Vir Biotechnology: Strong Balance Sheet But Commercial Prospects Await Further Clarity
- Vir Biotechnology GAAP EPS of -$1.22 beats by $0.03, revenue of $2.6M misses by $6.17M
For further details see:
Vir Biotechnology files for a mixed shelf offering